Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest epinephrine Stories

2013-08-14 08:29:14

This Back-to-School Season, Mylan Specialty L.P. Encourages People to be Better Prepared for a Life-Threatening Allergic Reaction BASKING RIDGE, N.J., Aug. 14, 2013 /PRNewswire/ -- Mylan Specialty L.P., the fully integrated specialty pharmaceutical business of Mylan Inc. (NASDAQ: MYL), today announced it is continuing the EpiPen4Schools(TM) program. In its first year, more than 20,000 schools across all 50 states participated in the program that offers four free EpiPen or EpiPen Jr(®)...

2013-07-16 22:33:21

Among patients who experienced in-hospital cardiac arrest requiring vasopressors (drugs that increase blood pressure), use of a combination therapy during cardiopulmonary resuscitation resulted in improved survival to hospital discharge with favorable neurological status, according to a study in the July 17 issue of JAMA. "Neurological outcome after cardiac arrest has been the main end point of several randomized clinical trials (RCTs). Neurologically favorable survival differs from...

2013-06-18 08:30:30

Inspired by the millions of people who have made EpiPen® (epinephrine) Auto-Injector the No. 1 prescribed epinephrine auto-injector for 25 years, Mylan Specialty's anniversary campaign educates, engages and gives back to the allergy community BASKING RIDGE, N.J., June 18, 2013 /PRNewswire/ -- Pro football player and 2012 most valuable player (MVP) Adrian Peterson and professional family expert Jo Frost have potentially life-threatening (severe) allergies and are partnering with...

2013-06-14 16:24:42

HORSHAM, Pa., June 14, 2013 /PRNewswire/ -- Amedra Pharmaceuticals LLC has announced re-launch of Adrenaclick®, a single-dose epinephrine auto-injector, for the emergency treatment of life threatening allergic reactions in people who are at risk for or have a history of anaphylaxis. Adrenaclick® will be available as a two-pack carton in both 0.15 mg and 0.30 mg strengths. For additional information about Adrenaclick® including prescribing information, please visit the...

2013-06-14 16:24:40

HORSHAM, Pa., June 14, 2013 /PRNewswire/ -- Lineage Therapeutics Inc. has announced the US launch of its generic epinephrine injection, USP auto-injector, the authorized generic of Adrenaclick® by Amedra Pharmaceuticals LLC, for the emergency treatment of life-threatening allergic reactions in people who are at risk for or have a history of anaphylaxis. The product is available as a two-pack carton in both 0.15 mg and 0.30 mg strengths. Lineage's epinephrine auto-injector is the only...

2013-06-12 08:20:27

Over half of Chicagoans say they look for adventure; Miami heads list of biggest spenders GREENVILLE, S.C., June 12, 2013 /PRNewswire/ -- Move aside Denver and Phoenix, it seems Chicagoans are the biggest thrill-seekers in the country, according to the new BFGoodrich® Tires Adrenaline Index. The tire maker surveyed 3,500 Americans across the country, revealing that more than one-third of Americans are self-proclaimed thrill seekers who thrive on new adventures and enjoy...

2013-05-29 12:26:42

In support of National Asthma and Allergy Awareness Month, Mylan goes to bat to help baseball fans with peanut allergies enjoy one of America's favorite pastimes BASKING RIDGE, N.J., May 29, 2013 /PRNewswire/ -- Mylan Specialty L.P., the fully integrated specialty pharmaceutical business of Mylan Inc. (Nasdaq: MYL), today announced it is partnering with an all-star roster of baseball teams to host Allergy Awareness games at select stadiums across the country. Mylan Specialty, the...

2013-05-16 08:27:49

- Bettis Unveils New Playbook for Defending Against Severe Allergic Reactions and Urges Those Affected to Take Action - BRIDGEWATER, N.J., May 16, 2013 /PRNewswire/ -- Professional football icon Jerome Bettis and Sanofi US, the makers of Auvi-Q(TM) (epinephrine injection, USP), have teamed up to raise awareness about severe allergic reactions (anaphylaxis) and introduce The Severe Allergy & Anaphylaxis Playbook - a collection of tips to help educate people living with severe...

2013-04-25 08:35:45

Marketer of EpiPen® Auto-Injector, the No. 1 prescribed epinephrine auto-injector, announces additional efforts to increase anaphylaxis awareness, preparedness and access to treatment for those affected by life-threatening allergies BASKING RIDGE, N.J., April 25, 2013 /PRNewswire/ -- Mylan Specialty L.P., the fully integrated specialty pharmaceutical business of Mylan Inc. (Nasdaq: MYL), is celebrating the 25(th) anniversary of the U.S. Food and Drug Administration's (FDA)...

2013-02-20 12:26:18

BASKING RIDGE, N.J., Feb. 20, 2013 /PRNewswire/ -- Since Mylan Specialty L.P., the fully-integrated specialty pharmaceutical business of Mylan Inc. (Nasdaq: MYL), launched the EpiPen4Schools(TM) program in August 2012, thousands of schools across the country have elected to participate and redeem free EpiPen(®) or EpiPen Jr(®) (epinephrine) Auto-Injectors. The program was created to help schools have improved access to epinephrine in the event a person experiences a life-threatening...